Peptonic Medical signs global agreement with Siemens Healthineers

Report this content

Peptonic Medical (PMED:SS) today announced that it has signed a non-exclusive agreement with the medical technology company Siemens Healthineers for the distribution of Peptonic’s portfolio of diagnostic products for vaginal health.

The agreement with Siemens Healthineers is global and non-exclusive. It centers around Peptonic's patented diagnostic products for vaginal health.

“This agreement is attractive from many aspects. We will get a very strong force in Siemens Healthineers that will help to raise awareness of the benefits of our unique and patented technology,” said Erik Sundquist, CEO of Peptonic Medical.

The agreement with Siemens Healthineers is expected to contribute positively to Peptonic’s revenues from 2024.

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care.

 

This disclosure contains information that PEPTONIC Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 20-04-2023 08:34 CET.

Erik Sundquist, CEO

Telefon: + 46 722 49 90 43

E-post: erik.sundquist@peptonicmedical.se

About Peptonic Medical AB

Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women’s health. Peptonic has divided its operations into two business areas: “Medical Consumer” and “Lifestyle Consumer”. The business area “Medical Consumer” is based on clinically proven intimate self-care and constitutes the company’s main focus and is sold under the VagiVital brand. The “Lifestyle Consumer” business area consists of lifestyle products with a focus on sustainable menstrual products and is sold under the Lunette brand. The company was founded in 2009 and the stock has been traded since 2014 on Spotlight (www.spotlightstockmarket.com) in Stockholm. More information about Peptonic Medical is available on www.peptonicmedical.se.

 

Subscribe

Documents & Links